Literature DB >> 31851975

Intradialytic Hypotension: Mechanisms and Outcome.

Benedict Sars1, Frank M van der Sande1, Jeroen P Kooman2.   

Abstract

Intradialytic hypotension (IDH) occurs in approximately 10-12% of treatments. Whereas several definitions for IDH are available, a nadir systolic blood pressure carries the strongest relation with outcome. Whereas the relation between IDH may partly be based on patient characteristics, it is likely that also impaired organ perfusion leading to permanent damage, plays a role in this relationship. The pathogenesis of IDH is multifactorial and is based on a combination of a decline in blood volume (BV) and impaired vascular resistance at a background of a reduced cardiovascular reserve. Measurements of absolute BV based on an on-line dilution method appear more promising than relative BV measurements in the prediction of IDH. Also, feedback treatments in which ultrafiltration rate is automatically adjusted based on changes in relative BV have not yet resulted in improvement. Frequent assessment of dry weight, attempting to reduce interdialytic weight gain and prescribing more frequent or longer dialysis treatments may aid in preventing IDH. The impaired vascular response can be improved using isothermic or cool dialysis treatment which has also been associated with a reduction in end organ damage, although their effect on mortality has not yet been assessed. For the future, identification of vulnerable patients based on artificial intelligence and on-line assessment of markers of organ perfusion may aid in individualizing treatment prescription, which will always remain dependent on the clinical context of the patient. The Author(s). Published by S. Karger AG, Basel.

Entities:  

Keywords:  Dialysis; Hemodialysis; Intradialytic hypotension; Pathophysiology

Mesh:

Year:  2019        PMID: 31851975      PMCID: PMC7114908          DOI: 10.1159/000503776

Source DB:  PubMed          Journal:  Blood Purif        ISSN: 0253-5068            Impact factor:   2.614


  93 in total

1.  Energy transfer is the single most important factor for the difference in vascular response between isolated ultrafiltration and hemodialysis.

Authors:  Frank M VAN DER Sande; Ulrich Gladziwa; Jeroen P Kooman; George Böcker; Karel M L Leunissen
Journal:  J Am Soc Nephrol       Date:  2000-08       Impact factor: 10.121

Review 2.  Catecholamine-induced changes in the splanchnic circulation affecting systemic hemodynamics.

Authors:  Simon Gelman; Phillip S Mushlin
Journal:  Anesthesiology       Date:  2004-02       Impact factor: 7.892

Review 3.  Effect of Lowering the Dialysate Temperature in Chronic Hemodialysis: A Systematic Review and Meta-Analysis.

Authors:  Reem A Mustafa; Fadi Bdair; Elie A Akl; Amit X Garg; Heather Thiessen-Philbrook; Hassan Salameh; Sood Kisra; Gihad Nesrallah; Ahmad Al-Jaishi; Parth Patel; Payal Patel; Ahmad A Mustafa; Holger J Schünemann
Journal:  Clin J Am Soc Nephrol       Date:  2015-12-28       Impact factor: 8.237

4.  Thermal effects and blood pressure response during postdilution hemodiafiltration and hemodialysis: the effect of amount of replacement fluid and dialysate temperature.

Authors:  Frank M VAN DER Sande; Jeroen P Kooman; Constantijn J Konings; Karel M L Leunissen
Journal:  J Am Soc Nephrol       Date:  2001-09       Impact factor: 10.121

5.  Ultrafiltration Rate and Mortality in Maintenance Hemodialysis Patients.

Authors:  Magdalene M Assimon; Julia B Wenger; Lily Wang; Jennifer E Flythe
Journal:  Am J Kidney Dis       Date:  2016-08-26       Impact factor: 8.860

6.  Hemodialysis-induced cardiac injury: determinants and associated outcomes.

Authors:  James O Burton; Helen J Jefferies; Nicholas M Selby; Christopher W McIntyre
Journal:  Clin J Am Soc Nephrol       Date:  2009-04-08       Impact factor: 8.237

Review 7.  Blood pressure regulation III: what happens when one system must serve two masters: temperature and pressure regulation?

Authors:  W Larry Kenney; Anna E Stanhewicz; Rebecca S Bruning; Lacy M Alexander
Journal:  Eur J Appl Physiol       Date:  2013-05-01       Impact factor: 3.078

8.  Randomized Crossover Trial of Blood Volume Monitoring-Guided Ultrafiltration Biofeedback to Reduce Intradialytic Hypotensive Episodes with Hemodialysis.

Authors:  Kelvin C W Leung; Robert R Quinn; Pietro Ravani; Henry Duff; Jennifer M MacRae
Journal:  Clin J Am Soc Nephrol       Date:  2017-10-10       Impact factor: 8.237

9.  Dialysate temperature reduction for intradialytic hypotension for people with chronic kidney disease requiring haemodialysis.

Authors:  Yasushi Tsujimoto; Hiraku Tsujimoto; Yukihiko Nakata; Yuki Kataoka; Miho Kimachi; Sayaka Shimizu; Tatsuyoshi Ikenoue; Shingo Fukuma; Yosuke Yamamoto; Shunichi Fukuhara
Journal:  Cochrane Database Syst Rev       Date:  2019-07-05

Review 10.  Neonatal Hemodynamics: From Developmental Physiology to Comprehensive Monitoring.

Authors:  Sabine L Vrancken; Arno F van Heijst; Willem P de Boode
Journal:  Front Pediatr       Date:  2018-04-05       Impact factor: 3.418

View more
  14 in total

1.  Correlation of NO and ET-1 Levels with Blood Pressure Changes in Hemodialysis Patients after Arteriovenous Fistula Surgery.

Authors:  Yanli Li; Hanxiao Lu; Yu Sun
Journal:  Front Surg       Date:  2022-05-16

2.  The effect of levocarnitine supplementation on dialysis-related hypotension: A systematic review, meta-analysis, and trial sequential analysis.

Authors:  Api Chewcharat; Pol Chewcharat; Weitao Liu; Jacqueline Cellini; Elizabeth A Phipps; Jill A Melendez Young; Sagar U Nigwekar
Journal:  PLoS One       Date:  2022-07-14       Impact factor: 3.752

3.  Pre-dialysis diastolic blood pressure and intradialytic hypotension in patients undergoing maintenance haemodialysis.

Authors:  Takashi Hara; Yuto Kasahara; Takahiko Nakagawa
Journal:  J Nephrol       Date:  2022-03-05       Impact factor: 4.393

4.  Primary kidney disease modifies the effect of comorbidities on kidney replacement therapy patients' survival.

Authors:  Jaakko Helve; Mikko Haapio; Per-Henrik Groop; Patrik Finne
Journal:  PLoS One       Date:  2021-08-20       Impact factor: 3.240

Review 5.  Management of acute intradialytic cardiovascular complications: Updated overview (Review).

Authors:  Delia Timofte; Maria-Daniela Tanasescu; Daniela Gabriela Balan; Adrian Tulin; Ovidiu Stiru; Ileana Adela Vacaroiu; Andrada Mihai; Cristian Constantin Popa; Cristina-Ileana Cosconel; Mihaly Enyedi; Daniela Miricescu; Raluca Ioana Papacocea; Dorin Ionescu
Journal:  Exp Ther Med       Date:  2021-01-26       Impact factor: 2.447

6.  Frequency of Intradialytic Complications in Patients of End-Stage Renal Disease on Maintenance Hemodialysis.

Authors:  Muhammad Ali; Ayesha Ejaz; Hina Iram; Shafique A Solangi; Abdul Manan Junejo; Sagheer Ahmed Solangi
Journal:  Cureus       Date:  2021-01-11

7.  Integrating Monitoring of Volume Status and Blood Volume-Controlled Ultrafiltration into Extracorporeal Kidney Replacement Therapy.

Authors:  Sebastian Zschätzsch; Manuela Stauss-Grabo; Adelheid Gauly; Jennifer Braun
Journal:  Int J Nephrol Renovasc Dis       Date:  2021-08-30

8.  Real-time prediction of intradialytic relative blood volume: a proof-of-concept for integrated cloud computing infrastructure.

Authors:  Sheetal Chaudhuri; Hao Han; Caitlin Monaghan; John Larkin; Peter Waguespack; Brian Shulman; Zuwen Kuang; Srikanth Bellamkonda; Jane Brzozowski; Jeffrey Hymes; Mike Black; Peter Kotanko; Jeroen P Kooman; Franklin W Maddux; Len Usvyat
Journal:  BMC Nephrol       Date:  2021-08-09       Impact factor: 2.388

Review 9.  Volume overload in hemodialysis: diagnosis, cardiovascular consequences, and management.

Authors:  Charalampos Loutradis; Pantelis A Sarafidis; Charles J Ferro; Carmine Zoccali
Journal:  Nephrol Dial Transplant       Date:  2021-12-02       Impact factor: 5.992

Review 10.  The Nephrologist's Role in the Collaborative Multi-Specialist Network Taking Care of Patients with Diabetes on Maintenance Hemodialysis: An Overview.

Authors:  Giuseppe Cavallari; Elena Mancini
Journal:  J Clin Med       Date:  2022-03-10       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.